Skip to main content

News, Announcements & Policies

Look here for up-to-date information from PLMS.
News & announcements

Announcements

PLMS discipline advisory committees newsletters

See the Provincial Discipline Advisory Committees page for the latest newsletters.

Bulletins

A bulletin from Perinatal Services BC and the Provincial Laboratory Medicine Services re: upcoming gestational diabetes testing changes in B.C.:


A memo from the Vancouver Coastal Health Division of Clinical Chemistry:


 

A memorandum from the BC COVID-19 Therapeutics Committee & the Thrombosis Program at Vancouver General Hospital to help guide the screening, diagnosis and management of VITT/TTS:


A bulletin from Dr. Blake Gilks, Chief Medical Laboratory Officer, Provincial Laboratory Medicine Services:


This guideline establishes a provincially consistent approach to handling requests from law enforcement officers to obtain laboratory specimens drawn for medical purposes. It is meant to address those instances not covered by the provincial guidelines for medical blood draws (November 2019).


Federal regulations for reporting all serious patient harm incidents related to the use of medical devices came into effect in December 2019. These regulations, referred to as Vanessa’s Law, require hospitals to report these events within thirty days of the event being documented in a hospital.


This guideline clarifies the responsibilities of medical laboratories in B.C. so that they operate in compliance with the law as well as meet the intent of the law, which is to safeguard patient safety.


‎The Ministry of Health recently approved fecal calprotectin testing for B.C. patients treated with a biologic agent (e.g. adalimumab, infliximab or vedolizumab).


Starting August 15, 2019, fecal calprotectin testing is available for patients who meet this clinical requirement. Fecal calprotectin testing for other clinical indications is not approved at this time, and therefore, is not funded by the Ministry after August 15.


Calprotectin is a protein released from white blood cells during the inflammatory process. Patients with inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease have high levels of calprotectin in their stool.


Fecal calprotectin is a non-invasive test used to monitor disease status and treatment efficacy. The amount of fecal calprotectin in a stool sample is proportional to the amount of intestinal inflammation; increases and decreases in fecal calprotectin concentration reflect bowel damage and healing, respectively.


Fecal calprotectin testing can be requested using the Standard Outpatient Laboratory Requisition. Only patients receiving biologic agents are eligible for MSP payable testing. Requests for all other clinical indications are patient-pay. For more information, please refer to the bulletins below.


Prompted by the introduction of “X” as an option for sex identification on government documents, laboratories across the province collaborated to develop best practice recommendations to meet the needs of our gender-diverse patients.


This guideline primarily addresses the laboratory registration of patients with the “X” sex identifier, provides a list of tests of interest when monitoring gender transitions, and provides guidance for managing reference ranges for gender-transitioning patients.


Officers of law enforcement agencies who suspect that an individual has been operating a motor vehicle while impaired have the right to demand a blood sample, as of December 18, 2018.


This laboratory bulletin is intended to provide provincial laboratory medicine leaders with general information and guidance concerning the Criminal Code amendments.


 

Guidelines & policies

Guidelines

Information on how Provincial Laboratory Medicine Services works in conjunction with BC Guidelines can be found at Guidelines and Protocols.

The complete list of the Ministry of Health's clinical guidelines can be found at BC Guidelines.

Policies

Laboratory Services Act Records of Decisions

When the Ministry of Health makes strategic and operational decisions in association with laboratory services, it issues an official record of decision and makes the content available to the public.

Please see the Laboratory Services Act Records of Decisions page under Laboratory Administration to see records of decision and ministerial orders.

Tab Heading
SOURCE: News, Announcements & Policies ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © Provincial Health Services Authority. All Rights Reserved.

    Copyright © 2024 Provincial Health Services Authority